Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Research Article Volume 4 Issue 11

Outcome of Adult and Pediatric Posterior Fossa Tumors Linked with Histopathological subtypes - Observations of Two Decades

Abdul Rashid Bhat1*, Muhammed Afzal Wani2 and Altaf Rehman Kirmani1

1Professor, Department of Neurosurgery, SKIMS Srinagar, Kashmir, India
2Professor and Head, Department of Neurosurgery, SKIMS Srinagar, Kashmir, India

*Corresponding Author: Abdul Rashid Bhat, Professor and Unit Head, Department of Neurosurgery, SKIMS Srinagar, Kashmir, India.

Received: March 19, 2021; Published: August 07, 2021


Objectives: To analyze the link between histopathological-type of posterior fossa tumors (PFTs) and the outcome in children and adults. The postoperative quality and span-of-life in these tumors is complicated by the residual disease, progression, recurrence, disabilities and mortality.

Materials and Methods: The histopathological records of 410 PFTs out of 589 patients were compared with their clinical outcome up to first postoperative-year in a single-centre, amounting to regional epidemiological-value. In this observational study, retrospectively postoperative records of 589 PFTs from November 1990 to December 2010 (20 years) were retrieved, scrutinized and compiled. The post-operative records of 410 patients with proved histopathological-examination results were included. The statistical law of Variance was applied where-ever necessary.

Results: The 63.2% of 410 operated PFTs were males while females predominated in meningiomas and pineoblastomas. About 31.7% PFTs were children (below-18yrs.). About 54.1% cases were histologically malignant. The residual-tumors comprised 40.2% and symptoms of disease-progression occurred in 10.9%. The tumor recurrence occurred in 14.3% while 6.0% patients developed severe-disability. The overall mortality was 11.4% up to first post-operative year with 18.9% in malignant patients. The first-one-year event free survival (EFS) for all the patients was 66.0%. While the patients with malignancies had first-one-year EFS of 47.7%, the histologically benign group had 87.7%.

Conclusion: The first one-year postoperative EFS of histologically benign and some malignant PFTs both in children and adults like pilocytic astrocytomas, ependymomas and pineoblastomas was much better (87.7%) than other malignant PFTs.

Keywords: Outcome; Posterior Fossa Tumours; Histopathological Subtypes; Children-adults


  1. Cushing H. “Experience with the cerebellar medulloblastoma: critical review”. Acta Pathologica Microbiologica Scandinavica 7 (1930): 1-86.
  2. Madjid S and Cordula M. “Management of 1000 Vestibular Schwannomas (Acoustic Neuromas): Surgical Management and Results with an Emphasis on Complications and How to Avoid Them”. Neurosurgery 40 (1997): 11-23.
  3. Seol HJ., et al. “Optimal extent of resection in vestibular schwannoma surgery: relationship to recurrence and facial nerve preservation”. Neurologia Medico-chirurgica (Tokyo) 46 (2006): 176-181.
  4. Yamakami I., et al. “Removal of large acoustic neurinomas (vestibular schwannomas) by the retrosigmoid approach with no mortality and minimal morbidity”. Journal of Neurology, Neurosurgery, and Psychiatry 75 (2004): 453-458.
  5. Roberti F., et al. “Posterior fossa meningiomas: surgical experience in 161 cases”. Surgical Neurology 56 (2001): 8-20.
  6. Velho V., et al. “Posterior fossa meningioma “our experience” in 64 cases”. Asian Journal of Neurosurgery 7 (2012): 116-124.
  7. Hakuba A., et al. “Clivus Meningioma: Six cases of total removal”. Neurologia Medico-chirurgica 17 (1977): 63-77.
  8. Coudwell WT., et al. “Petroclival meningioma, Surgical experience in 109 cases”. Journal of Neurosurgery 84 (1996): 20-28.
  9. Louis DN., et al. “The 2007 WHO classification of tumours of the central nervous system”. Acta Neuropathology 114 (2007): 97-109.
  10. Gläsker S. “Central nervous system manifestations in VHL: Genetics, pathology and clinical phenotypic features”. Family Cancer 4 (2005): 37-42.
  11. Benzagmout M., et al. “Dermoid cyst of the posterior fossa”. Neurosciences 16 (2011): 153-155.
  12. Bauman CH., et al. “Paratrigeminal epidermoid tumors”. Journal of Neurosurgery 13 (1956): 455-468.
  13. Zakrzewski K., et al. “Posterior fossa tumours in children and adolescents. A clinicopathological study of 216 cases”. Folia Neuropathology 41 (2003): 251-252.
  14. Muzumdar D., et al. “Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patients”. Journal of Pediatric Neurosciences 6 (2001): S78-S85.
  15. Rutka JT. “Medulloblastoma”. Clinical Neurosurgery 44 (1997): 571-85.
  16. Bloom HJ and Bessell EM. “Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981”. International Journal of Radiation Oncology • Biology • Physics 18 (1990): 763-772.
  17. Chan AW., et al. “Adult medulloblastoma: prognostic factors and patterns of relapse”. Neurosurgery 47 (2000): 623-632.
  18. Glaser SL., et al. “Cancer surveillance research: a vital subdiscipline of cancer epidemiology”. Cancer Causes Control 16 (2005): 1009-1019.
  19. Carrie C., et al. “Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients”. Cancer 74 (1994): 2352-2360.
  20. Djalilian HR and Hall WA. “Malignant gliomas of the cerebellum: an analytic review”. Journal of Neurooncology 36 (1998): 247-257.
  21. Witt H., et al. “Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma”. Cancer Cell 20 (2011): 143-157.
  22. Desai KI., et al. “Prognostic factors for cerebellar astrocytomas in children. A study of 102 cases”. Pediatric Neurosurgery 35 (2001): 311-317.
  23. Daszkiewicz P., et al. “Long term functional outcome of surgical treatment of juvenile pilocytic astrocytomas of the cerebellum in children”. Child's Nervous System 25 (2009): 855-860.
  24. Lesniak MS., et al. “Surgical outcome following resection of contrast-enhanced pediatric brainstem gliomas”. Pediatric Neurosurgery 39 (2003): 314-322.
  25. Donaldson SS., et al. “Advances toward an understanding of brain stem gliomas”. Journal of Clinical Oncology 24 (2006): 1266-1272.
  26. Sunderland GJ., et al. “Surgical management of posterior fossa metastases”. Journal of Neuro-Oncology 130 (2016): 535-542.
  27. Zhang X., et al. “A review of current management of brain metastases”. Annals of Surgical Oncology 19 (2012): 1043-1050.
  28. Tate M, ., et al. “The Long-Term Postsurgical Prognosis of Patients with Pineoblastoma”. Cancer 118 (2012): 173-179.
  29. Wang YC., et al. “Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas”. Scientific Reports 6 (2016): 35743.


Citation: Abdul Rashid Bhat., et al. “Outcome of Adult and Pediatric Posterior Fossa Tumors Linked with Histopathological subtypes - Observations of Two Decades”. Acta Scientific Neurology 4.11 (2021): 03-11.


Copyright: © 2021 Abdul Rashid Bhat., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US